Vident Advisory, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1744347 Alpharetta, GA

Position in TEVA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,498,288

-$77,066 QoQ

Shares Held

49,744

-1.5% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 65.8511579285944.ToString("F0")% Shared 0.ToString("F0")% None 34.148842071405596.ToString("F0")%

Healthcare · as of Mar 31, 2026

Vident Advisory, LLC holds $33,979,992 across 23 Drug Manufacturers - Specialty & Generic names. TEVA ranks #7 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	52,710	$6,230,847
2	VTRS	Viatris Inc	350,648	$4,737,253
3	UTHR	UNITED THERAPEUTICS Corp	6,039	$3,581,004
4	RDY	Dr Reddys Laboratories Ltd	217,581	$3,013,496
5	ALKS	Alkermes plc.	84,090	$2,973,422
6	HLN	Haleon plc	235,522	$2,357,574
7	TEVA	Teva Pharmaceutical Industries Ltd This page	49,744	$1,498,288
8	TAK	Takeda Pharmaceutical Co Ltd	75,036	$1,389,666

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,498,288	49,744	-1.5%	Shares	Defined	2026-05-15
2025-12-31	$1,575,354	50,476	-9.3%	Shares	Defined	2026-02-18
2025-09-30	$1,124,331	55,660	+40.1%	Shares	Defined	2025-11-14
2025-06-30	$665,791	39,725	-8.4%	Shares	Defined	2025-08-14
2025-03-31	$666,366	43,355	+0.5%	Shares	Defined	2025-05-15
2024-12-31	$951,246	43,160	-5.1%	Shares	Defined	2025-02-14
2024-09-30	$819,675	45,487	-2.3%	Shares	Defined	2024-11-14
2024-06-30	$756,551	46,557	+14.3%	Shares	Defined	2024-08-14
2023-12-31	$425,242	40,732	+39.7%	Shares	Defined	2024-02-14
2023-09-30	$297,350	29,152	—	Shares	Defined	2024-02-21
No filing history on record for this holder in this stock.